The Effect Of Tropical Fruits In Patients With Primary Glaucoma
NCT ID: NCT06071494
Last Updated: 2025-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
104 participants
INTERVENTIONAL
2024-02-01
2025-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methodology :
Research Design Randomized controlled trial
Study Duration February 2024-June 2025
Study Location
1\. Ophthalmology Clinic, Hospital Universiti Sains Malaysia, Kelantan
Source Reference Population Adults with primary glaucoma in Peninsular Malaysia
Study Source Population Adults with primary glaucoma attending Ophthalmology clinic, Hospital Universiti Sains Malaysia during study duration.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Green Tea Consumption on Primary Glaucoma
NCT06235827
Primary Glaucoma Treatment Trial in Kenya and South Africa - SLT vs. Medication
NCT02774811
Prospective Evaluation of the Efficacy of Pascal Laser Iridotomy and Pascal Laser Peripheral Iridoplasty: A Pilot Study
NCT01020071
A Comparative Study of Intraocular Pressure Control Using Selective Laser Trabeculoplasty and Latanoprost as Initial Treatments for Primary Open Angle Glaucoma and Ocular Hypertension in Lagos State University Teaching Hospital
NCT07310719
Micropulse Laser Trabeculoplasty as Adjunctive Treatment in Patients With Pseudoexfoliation Glaucoma
NCT03483402
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Research hypothesis
1. There is a significant different in the IOP measurement between those whose taking regular tropical fruits and not taking them at baseline, 1 month, 3 month and 6 month among patients with primary glaucoma.
2. There is a significant different in RNFL thickness between those whose taking regular tropical fruits and not taking them at baseline, 1 month, 3 month and 6 month among patients with primary glaucoma.
Inclusion Criteria
1. Patient with confirmed diagnosis of POAG and PACG
2. Patient on medical treatment and achieved target IOP in last 6 months
3. Good compliance with pressure lowering agents
Exclusion Criteria
1. Poorly controlled diabetes mellitus, hypertension and hyperlipidaemia
2. Active smoker
3. Mentally challenge based on diagnosis
4. History of previous intraocular surgery other than uncomplicated cataract surgery within past 6 months
5. Poor signal strength OCT RNFL
6. Patient with media opacities that affect the reliability of OCT measurements , such as Cornea opacity, dense cataract with LOCS III of more than grade 2, vitreous haemorrhage
7. Other optic neuropathy apart from glaucoma
8. History of taking antioxidant supplement 3 months prior to recruitment.
Methods of Data Collection
This study will be conducted after obtaining ethical approval from the Universiti Sains Malaysia Ethical Committee (JPeM) and will be conducted in accordance to World Medical Association Declaration of Helsinki ethical principles for medical research involving human subjects.
Recruitment of Subject
Patient diagnosed with POAG and PACG attending Ophthalmology clinic, Hospital USM during study duration and fulfilled study inclusion and exclusion criteria. An informed and written consent will be taken and information form given to patients. The selected patients will be randomized into 2 groups (A and B) using sequentially numbered, opaque sealed envelopes (SNOSE). Group A patient will be consuming the chosen fruits and group B patient will not consume them.
Interventional Protocol
Patients in Group A will have to consume 2 types of fresh fruits per week as 2 servings once per day, daily for a 6-month duration. The chosen fruits are papaya, banana, mango and orange, and 2 types of fruits per week will be determined by the primary investigator. Size of the servings is according to the Malaysian Dietary Guideline 2020. They must eat them raw, and not to process or cook them in any other way. The fruits will be distributed by research assistant weekly throughout the study period. Patient will be reminded weekly using text messages or phone call by a research assistant for the fruit's consumption. Patients in group A and group B will be given a dietary diary throughout the study period, where the patient will mark the intake of fruits listed. The purpose of the diary is also to monitor patient intake of the fruits and daily diet as well.
IOP measurement
IOP measurement will be done using Goldmann Applanation Tonometer (GAT) in sitting position by the primary investigator (Nurul Munirah) who will be blinded. GAT will be calibrated daily before use to measure the IOP. Measurement of IOP will be done only at 8am - 10am (to prevent diurnal variation). Before IOP measurement, subjects are advised to avoid drinking coffee or any caffeinated drink 24 hours before and only to take light meal 2 hours before (to reduce the effect of hyperglycaemia and hydration on IOP). Only one eye will be measured, if both eyes are eligible, only right eye will be selected regardless of severity of glaucoma. Three readings of IOP will be measured and the mean reading will be taken as result. IOP measurement will be taken at baseline, first, third and sixth month post recruitment for group A and B.
OCT evaluation on RNFL thickness
Spectral domain Cirrus HD-OCT will be used to measure RNFL thickness and ONH parameters by a trained personnel who is blinded. Patient's eye will be dilated and patient will sit and rest his/her head on a support to keep it motionless in front of the OCT machine. The OCT will then scan patient's eye without touching it. Scans with signal strength less than 6, eye movement or blinking artifacts within the 1.73-mm radius around the ONH, or with segmentation errors will be repeated. If there is unsatisfactory measurement after 3 attempts, the patient will be excluded from the study. OCT will be conducted at baseline, first, third and sixth month post recruitment for group A and B.
Data Entry and Statistical Analysis
The data entry and analysis will be performed by using Statistical Package for the Social Sciences (SPSS) version 29 licensed to USM.
* Paired T-test
* Chi-square test
* A one-way repeated measures analysis of variance (RM ANOVA)
Plans for minimizing study errors
These steps will be taken to minimize the errors while conducting the study:
* The same instruments and equipment will be used for repeated measurement in this study.
* The measurement of IOP will be done at the same time (8am-10am) in a day for all patients (to prevent diurnal variation).
* OCT measurements will be performed by qualified and trained personnel only.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tropical Fruits
patient will be consuming the chosen fruits, according to the size of the serving following Malaysian Dietary Guideline 2020
Tropical fruits
papaya, mango, banana, orange
Normal diet
patient will consume normal diet as usual
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tropical fruits
papaya, mango, banana, orange
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient on medical treatment and achieved target IOP in last 6 months
3. Good compliance with pressure lowering agents
Exclusion Criteria
2. Active smoker
3. Mentally challenge based on diagnosis
4. History of previous intraocular surgery other than uncomplicated cataract surgery within past 6 months
5. Poor signal strength OCT RNFL
6. Patient with media opacities that affect the reliability of OCT measurements , such as Cornea opacity, dense cataract with LOCS III of more than grade 2, vitreous haemorrhage
7. Other optic neuropathy apart from glaucoma
8. History of taking antioxidant supplement 3 months prior to recruitment
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universiti Sains Malaysia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
NURUL MUNIRAH BINTI MOHAMAD
Principle Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nurul Munirah Mohamad, Dr
Role: PRINCIPAL_INVESTIGATOR
Department of Ophthalmology School of Medical Sciences Universiti Sains Malaysia,Health Campus.
Liza Sharmini Ahmad Tajudin, Prof. Dr.
Role: STUDY_CHAIR
Department of Ophthalmology School of Medical Sciences Universiti Sains Malaysia,Health Campus.
Rohana Abd Jalil, Ass. Prof.
Role: STUDY_DIRECTOR
Department of Ophthalmology School of Medical Sciences Universiti Sains Malaysia,Health Campus.
Fatimah Suhaila Sukaimy, Dr
Role: STUDY_DIRECTOR
Department of Ophthalmology Hospital Tengku Ampuan Afzan, Ministry of Health, Malaysia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Univerisiti Sains Malaysia
Kubang Kerian, Kota Bharu, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004 May 22;363(9422):1711-20. doi: 10.1016/S0140-6736(04)16257-0.
Braakhuis A, Raman R, Vaghefi E. The Association between Dietary Intake of Antioxidants and Ocular Disease. Diseases. 2017 Jan 30;5(1):3. doi: 10.3390/diseases5010003.
Kang JH, Willett WC, Rosner BA, Buys E, Wiggs JL, Pasquale LR. Association of Dietary Nitrate Intake With Primary Open-Angle Glaucoma: A Prospective Analysis From the Nurses' Health Study and Health Professionals Follow-up Study. JAMA Ophthalmol. 2016 Mar;134(3):294-303. doi: 10.1001/jamaophthalmol.2015.5601.
Neufeld AH, Sawada A, Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9944-8. doi: 10.1073/pnas.96.17.9944.
Related Links
Access external resources that provide additional context or updates about the study.
Primary open-angle glaucoma
The Association between Dietary Intake of Antioxidants and Ocular Disease. Diseases
Association of Dietary Nitrate Intake With Primary Open-Angle Glaucoma: A Prospective Analysis From the Nurses' Health Study and Health Professionals Follow-up Study
Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RSCH ID-23-03744-7U6
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.